First, we identify the CK2α-DUB3 axis as an uncharacterized upstream signaling pathway regulating cellular YAP1 abundance in multiple cancer types including ovarian cancer, which critically contributes to tumor progression and chemotherapy resistance. This evidence concerns the gene USP17L2 and ovarian carcinoma.